FOR IMMEDIATE RELEASE

Ezalife announced compelling clinical results demonstrating that its Button Huggie® device achieved a 77% reduction in feeding tube dislodgement, addressing a long-standing challenge in patient care.

Feeding tubes, commonly secured with tape and gauze, have remained largely unchanged for decades, often leading to discomfort, complications, and emergency interventions. Ezalife’s solution introduces a purpose-built, FDA-registered device designed to stabilize G-buttons more effectively.

In addition to clinical improvements, EzaLife reported strong patient and caregiver satisfaction metrics:

• Approximately 270% increase in parent satisfaction compared to traditional methods

• Net Promoter Score of 76, significantly higher than the industry average of 46

“These results highlight both the clinical effectiveness and the real-world impact on families,” the company stated. “We’re not just improving outcomes, we’re improving daily life.”

The Button Huggie® is protected by a granted U.S. patent with 18 claims, along with additional international patents across Europe, the UK, Canada, China, and Japan, reinforcing Ezalife’s position as a category innovator.

By addressing a critical yet underserved segment of the $1.9 billion feeding tube market, Ezalife is positioning itself as a disruptive force in post-operative and long-term care.

As its StartEngine campaign approaches its April 6 close, the company continues to attract attention from investors seeking opportunities at the intersection of healthcare innovation and proven clinical validation.

https://www.startengine.com/offering/ezalife

Ezalife develops precision-engineered medical devices to improve the safety and quality of life for patients requiring feeding tubes. Its mission is to replace outdated standards of care with innovative, patient-centered solutions.

Contact

Kara Fagan

Chief Marketing Officer

kfagan@ezalife.com

4198226296

Columbus, OH